| 000 | 01511 a2200385 4500 | ||
|---|---|---|---|
| 005 | 20250511180035.0 | ||
| 264 | 0 | _c19920612 | |
| 008 | 199206s 0 0 eng d | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPotter van Loon, B J | |
| 245 | 0 | 0 |
_aFluoxetine increases insulin action in obese nondiabetic and in obese non-insulin-dependent diabetic individuals. _h[electronic resource] |
| 260 |
_bInternational journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity _cFeb 1992 |
||
| 300 |
_a79-85 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aC-Peptide _xblood |
| 650 | 0 | 4 |
_aDiabetes Mellitus, Type 2 _xcomplications |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFluoxetine _xpharmacology |
| 650 | 0 | 4 |
_aGlucose _xbiosynthesis |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInsulin _xmetabolism |
| 650 | 0 | 4 | _aInsulin Secretion |
| 650 | 0 | 4 |
_aLiver _xdrug effects |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aMultivariate Analysis |
| 650 | 0 | 4 |
_aObesity _xcomplications |
| 700 | 1 | _aRadder, J K | |
| 700 | 1 | _aFrölich, M | |
| 700 | 1 | _aKrans, H M | |
| 700 | 1 | _aZwinderman, A H | |
| 700 | 1 | _aMeinders, A E | |
| 773 | 0 |
_tInternational journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity _gvol. 16 _gno. 2 _gp. 79-85 |
|
| 999 |
_c1322853 _d1322853 |
||